Genetics of Parkinsonism in a Special Population of Untreated Schizophrenia
未经治疗的精神分裂症特殊人群中帕金森症的遗传学
基本信息
- 批准号:8032861
- 负责人:
- 金额:$ 16.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgeAggressive behaviorAntipsychotic AgentsArgentinaAttentionAttitude to HealthAwardBloodBlood specimenBradykinesiaCharacteristicsClassificationClinicalCognitiveCognitive deficitsCollectionConsentControl GroupsDNADataDatabasesDeltastabDependenceDevelopmentDiagnosisDiagnosticDiamondDimensionsEarly DiagnosisEarly treatmentEnrollmentEpidemiologyEquipment and supply inventoriesFirst Degree RelativeFundingFutureGeneral PopulationGenesGeneticGenetic VariationGenomicsGoalsHealthHealth systemHeritabilityHigh PrevalenceImageImpairmentIndividualInstitutionInterviewLanguageLifeLinkMaster&aposs DegreeMeasuresMemory impairmentMental HealthMental disordersMentorshipMidbrain structureMotorMovementMovement DisordersMultivariate AnalysisMuscle RigidityNeurobiologyNeurocognitiveNeurologicNeurologic ExaminationNeurologistNeurologyNewly DiagnosedNicotineNicotine DependenceNoiseOutcomeParkinson DiseaseParkinsonian DisordersParticipantPathway interactionsPatientsPatternPharmaceutical PreparationsPhenotypePopulationPopulation ControlPredispositionPrevalencePreventionPrincipal InvestigatorProvincePsychiatristPsychiatryPsychotic DisordersQuality of lifeQuantitative Trait LociRecruitment ActivityResearchResearch PersonnelRiskSamplingScanningScheduleSchizophreniaSeveritiesSex EducationShort-Term MemorySiblingsSignal TransductionSingle Nucleotide PolymorphismSmokeSmokerSmokingSubstance AddictionSubstantia nigra structureSurveysSymptomsSyndromeTemperamentTestingTrainingTransportationTremorUltrasonographyUniversitiesVisuospatialWashingtonWorkbasecareercase controlclinical Diagnosiscompliance behaviordeficit syndromedesignendophenotypeexecutive functionfield surveygenetic epidemiologygenome wide association studyimprovedindexingmRNA Expressionmedical schoolsmeetingsmotor impairmentnamed groupneurobiological mechanismneuropsychiatryneuropsychologicalnon-smokeroutreachpatient populationpreventprobandprofessorprogramsprotective effectsmoking prevalencetooltrait
项目摘要
DESCRIPTION (provided by applicant): The candidate is a neurologist/psychiatrist with training in neurobiology, and an assistant professor of psychiatry and neurology at the Washington University School of Medicine (WUStL), a world leading institution in genetics and epidemiology of psychiatric disorders. The candidate's immediate goal is to complete a master's degree in epidemiology and genetics to maximize opportunities afforded by his currently funded research and under the mentorship of Dr. Cloninger and Dr. Goate. His long term goal is to concentrate his research career on the study of the genetic control of the relationship between parkinsonism and schizophrenia. Project. Parkinsonism is highly prevalent in newly diagnosed -untreated- patients with schizophrenia; its presence predicts greater susceptibility to neuroleptic-induced side effects, reduced treatment compliance and poorer outcome. Smoking has a negative association with parkinsonism, whereas hyperechogenicity of the substantia nigra, executive function and working memory deficits, and increased harm avoidance on the temperament and character inventory are all positively associated with motor impairment. These diverse phenotypic manifestations are related to a single neurobiological mechanism, namely decreased dopaminergic function. Studying untreated patients prevents the noise introduced into such phenotypic manifestations by the effects of antipsychotic drugs, and therefore will permit isolation of the genetic signal from environmental noise (represented by treatment). We identified a population with untreated schizophrenia, and collected a pilot sample to study the clinical, neuropsychological and neurological characteristics of patients, their first degree relatives, and culturally appropriate controls. We propose to expand the sample. With the funds of this award we will focus on the clinical characterization of the probands and their siblings as well as of controls and their siblings to investigate the heritability of a composite endophenotype including parkinsonism, smoking, cognitive deficit and hyperechogenicity of the substantia nigra. Towards the end of the award period we will work on an Roi application to study the relationship of the proposed phenotype to quantitative trait loci (QTL). The major relevance of the proposed research lies on the possibility of testing if a neurobiologically well defined set of individual characteristics is genetically determined. Because these deficits possibly predate the onset of psychosis, we believe our strategy might provide tools for early detection and early intervention, possibly leading to prevention of psychosis in subjects at-risk for schizophrenia. Lastly, we anticipate that our research strategy may indicate new ways to study and address the increased vulnerability of schizophrenic patients to nicotine dependence.
描述(由申请人提供):候选人是一名神经学家/精神病学家,接受过神经生物学培训,是华盛顿大学医学院(WUSTL)的精神病学和神经病学助理教授,WUSTL是精神疾病遗传学和流行病学的世界领先机构。候选人的近期目标是完成流行病学和遗传学硕士学位,以最大限度地利用他目前资助的研究所提供的机会,并在Cloninger博士和Goate博士的指导下。他的长期目标是将他的研究生涯集中在帕金森症和精神分裂症之间关系的遗传控制研究上。项目帕金森综合征在新诊断的精神分裂症患者中非常普遍;它的存在预示着更容易受到抗精神病药诱导的副作用,降低治疗依从性和不良结局。吸烟与帕金森综合征呈负相关,而黑质的强回声性、执行功能和工作记忆缺陷以及气质和性格量表上的伤害回避增加均与运动障碍呈正相关。这些不同的表型表现与单一的神经生物学机制有关,即多巴胺能功能降低。研究未经治疗的患者可以防止抗精神病药物的作用引入这种表型表现的噪音,因此可以将遗传信号从环境噪音(由治疗代表)中分离出来。我们确定了一个未经治疗的精神分裂症人群,并收集了一个试点样本,以研究患者的临床,神经心理学和神经学特征,他们的一级亲属,和文化上适当的控制。我们建议扩大样本。有了这笔资金,我们将专注于先证者及其兄弟姐妹以及对照组及其兄弟姐妹的临床表征,以调查复合内表型的遗传性,包括帕金森综合征,吸烟,认知缺陷和黑质的高回声性。在奖励期结束时,我们将致力于研究所提出的表型与数量性状基因座(QTL)的关系。拟议的研究的主要相关性在于测试神经生物学明确定义的一组个体特征是否由遗传决定的可能性。由于这些缺陷可能早于精神病的发作,我们相信我们的策略可能会提供早期发现和早期干预的工具,可能会导致预防精神分裂症风险受试者的精神病。最后,我们预计,我们的研究策略可能会指出新的方法来研究和解决精神分裂症患者对尼古丁依赖的脆弱性增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABRIEL Alejandro DE ERAUSQUIN其他文献
GABRIEL Alejandro DE ERAUSQUIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABRIEL Alejandro DE ERAUSQUIN', 18)}}的其他基金
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
South Texas Alzheimer's Disease Center Clinical Core
南德克萨斯阿尔茨海默病中心临床核心
- 批准号:
10270729 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
Multidisciplinary Training Program on Neuropsychiatry and Behavioral Disorders in First Nations (NEUFIN)
原住民神经精神病学和行为障碍多学科培训计划 (NEUFIN)
- 批准号:
10302693 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
Multidisciplinary Training Program on Neuropsychiatry and Behavioral Disorders in First Nations (NEUFIN)
原住民神经精神病学和行为障碍多学科培训计划 (NEUFIN)
- 批准号:
10483189 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
South Texas Alzheimer's Disease Center Clinical Core
南德克萨斯阿尔茨海默病中心临床核心
- 批准号:
10662340 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
Multidisciplinary Training Program on Neuropsychiatry and Behavioral Disorders in First Nations (NEUFIN)
原住民神经精神病学和行为障碍多学科培训计划 (NEUFIN)
- 批准号:
10669755 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
South Texas Alzheimer's Disease Center Clinical Core
南德克萨斯阿尔茨海默病中心临床核心
- 批准号:
10472665 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 16.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 16.24万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 16.24万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 16.24万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 16.24万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 16.24万 - 项目类别:
Studentship














{{item.name}}会员




